NCT02156323View on ClinicalTrials.gov

A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Healthy Volunteer

Interventions

DRUG

CMS

Multiple doses of CMS over 2.5 days

DRUG

RO7033877

Multiple doses of RO7033877 over 2.5 days

DRUG

RO7033877 + CMS

Multiple doses of RO7033877 and CMS over 2.5 days

Trial Locations (1)

9471 GP

Zuidlaren

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02156323 - A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS) | Biotech Hunter | Biotech Hunter